The scope of this research service is to provide an in-depth analysis of the contract research opportunities available in the European therapeutic market. It analyses the revenue potential, market dynamics, trends and competitive structure. The European Contract Research Outsourcing (CRO) revenues have been derived from the preclinical and clinical services offered by contract research organisations to pharmaceutical and biotechnology sponsors in conducting clinical trials. The markets analysed in this research service have been approached from a service provider’s point of view. The CRO market has been exclusively segmented based on stages of clinical trials, therapeutic services and geographies.